Global law firm Goodwin announced today the addition of Delphine O’Rourke as partner in the firm’s Healthcare and Life Sciences practices, resident in the New York office. O’Rourke joins the firm from Duane Morris in Philadelphia.

O’Rourke is trusted counsel to health industry leaders. She counsels health companies, hospitals & healthcare systems, and investors on the regulatory frameworks that drive their business. Clients rely on O’Rourke’s deep knowledge of healthcare law and policy as well as her experience as a health care executive and in-house general counsel. She served as Associate General Counsel of Ascension and in her decades plus with Ascension, she served in legal roles of increasing responsibility for the $23 billion health enterprise.

O’Rourke’s healthcare regulatory practice focuses on:

• Compliance with federal laws & regulations governing access, delivery and payment for medical care in the United States including EMTALA, the federal Anti-Kickback Statute, Stark Law, patient care issues, medical staff matters, licensure, accreditation and tax exemption
• Strategic affiliations & investments including complex provider and multi-system transactions, due diligence on behalf of private equity clients and critical supply chain relationships
• Emergency management, public health & crisis communications including currently advising a wide range of companies and providers on the legal issues relating to COVID-19

She is a regular speaker on cutting edge healthcare regulatory developments and contributor to leading legal and industry publications and podcasts including Modern Healthcare, Law360 and the American Health Law Association. O’Rourke is nationally recognized for her commitment to the advancement of women and inclusionary leadership.

“Structural shifts in reimbursement models, consolidation, a digital revolution, a trend toward consumerism, and a complex and evolving regulatory landscape are challenging the status quo and creating opportunities for companies and investors in the healthcare space,” said David Cappillo, co-chair of Goodwin’s Healthcare practice. “Delphine’s highly specialized regulatory, transactional, and compliance expertise will help our clients capitalize on the industry’s evolution. Her robust skillset complements Goodwin’s existing strengths in healthcare services, healthcare IT, and digital health transactions, litigation, and regulatory advisory as we continue to invest in our platform at the intersection of capital and innovation.”

Chris Wilson, co-chair of Goodwin’s Healthcare practice, added: “We are thrilled to have Delphine join us. Her practice perfectly aligns with our focus on building a premier, full-service healthcare practice.”

O’Rourke received her undergraduate degree from Georgetown University and her J.D. from Columbia University. She is admitted to practice law in Pennsylvania, New Jersey, and New York State, is barred with the Supreme Court of the United States and the United States District Court for the Southern District of New York, and is a member of the American Bar Association and the American Health Law Association.

She can be reached at or (212) 459.7423.

Goodwin’s Healthcare practice counsels healthcare service providers, life sciences companies, digital health enterprises, fund sponsors and their portfolio companies, and investors on transactions, regulatory matters, government investigations, and litigation. The multidisciplinary team encompasses a number of traditional law practices such as corporate, M&A, finance, litigation, intellectual property, privacy, and FDA, and includes healthcare industry specialists from the firm’s Technology, Life Sciences, Private Equity, and Litigation practices. Mergermarket has named Goodwin the number one legal advisor for Life Sciences and Healthcare M&A (by Deal Count) in its Deal Drivers Americas 2019 M&A League Tables.